Clinical Trial Update: A Study of BGM0504 Injection in Participants with Obesity or Overweight [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating BGM0504 Injection in adults with overweight or obesity; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• BGM0504 Injection (BGM0504)

Snippet

Sponsor: BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd. | Conditions: Overweight or Obesity | Phase 3 | Status: RECRUITING